Victoria Attaya (Cari Ryding)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Diffusion Weighted Imaging

Mesenchymal Stem Cells

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Bojana Jovanovic, Sarah E Church, Kara M Gorman, Khrystyna North, Edward T Richardson, Molly DiLullo, Victoria Attaya, Julie Kasparian, Ayesha Mohammed-Abreu, Gregory Kirkner, Melissa E Hughes, Nancy U Lin, Elizabeth A Mittendorf, Stuart J Schnitt, Sara M Tolaney, Shom Goel
Integrative multi-omic profiling of triple-negative breast cancer for identifying suitable therapies. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Aditya Bardia, Sheng Sun, Nayana Thimmiah, James T T Coates, Bogang Wu, Rachel Occhiogrosso Abelman, Laura M Spring, Beverly Moy, Phoebe Ryan, Mark N Melkonyan, Ann H Partridge, Dejan Juric, Jeffrey M Peppercorn, Heather A Parsons, Seth A Wander, Victoria Attaya, Brenda Lormil, Maria Shellock, Aiko Nagayama, Veerle Bossuyt, Steven Jay Isakoff, Sara M Tolaney, Leif W Ellisen
Antibody Drug Conjugate Sacituzumab Govitecan Enables A Sequential TOP1/PARP Inhibitor Cancer Therapy Strategy in Breast Cancer Patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Adrienne G Waks, Emily L Chen, Noah Graham, Anna Mae Frey, Kenneth Almeida, Victoria Attaya, Victoria Attaya, Ibrahim M Abbass, Anita Fung, Jesse Sussell, Patricia Cortazar, Caroline Harvey, Denise Leth, Meredith Faggen, Natalie Sinclair, Jeanna Walsh, Nadine M Tung, Sarah Sinclair, Steve Lo, Denise Yardley, Vicente Valero, Jane Meisel, Tarah Jean Ballinger, Sylvia Adams, Lisa Anne Carey, Julia K Rauch, Vandana G Abramson, Nicole O Williams, Wendy Y Chen, José Pablo Leone, Susan T Schumer, Nabihah Tayob, Sara M Tolaney
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial). JCO oncology practice (2024)
Aditya Bardia, Sheng Sun, Nayana Thimmiah, James T T Coates, Bogang Wu, Rachel Occhiogrosso Abelman, Laura M Spring, Beverly Moy, Phoebe Ryan, Mark N Melkonyan, Ann H Partridge, Dejan Juric, Jeffrey M Peppercorn, Heather A Parsons, Seth A Wander, Victoria Attaya, Brenda Lormil, Maria Shellock, Aiko Nagayama, Veerle Bossuyt, Steven Jay Isakoff, Sara M Tolaney, Leif W Ellisen
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Aditya Bardia, Sheng Sun, Nayana Thimmiah, James T T Coates, Bogang Wu, Rachel Occhiogrosso Abelman, Laura M Spring, Beverly Moy, Phoebe Ryan, Mark N Melkonyan, Ann H Partridge, Dejan Juric, Jeffrey M Peppercorn, Heather A Parsons, Seth A Wander, Victoria Attaya, Brenda Lormil, Maria Shellock, Aiko Nagayama, Veerle Bossuyt, Steven Jay Isakoff, Sara M Tolaney, Leif W Ellisen
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Aditya Bardia, Sheng Sun, Nayana Thimmiah, James T T Coates, Bogang Wu, Rachel Occhiogrosso Abelman, Laura M Spring, Beverly Moy, Phoebe Ryan, Mark N Melkonyan, Ann H Partridge, Dejan Juric, Jeffrey M Peppercorn, Heather A Parsons, Seth A Wander, Victoria Attaya, Brenda Lormil, Maria Shellock, Aiko Nagayama, Veerle Bossuyt, Steven Jay Isakoff, Sara M Tolaney, Leif W Ellisen
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)